ARTICLE | Company News
Zosano, Novo Nordisk deal
August 17, 2015 7:00 AM UTC
Zosano said Novo Nordisk will terminate a 2014 deal granting Novo exclusive, worldwide rights to develop and commercialize Novo’s glucagon-like peptide-1 (GLP-1) analogs using Zosano’s microneedle pa...